Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06474429 · ClinicalTrials.gov registry record
Assessing the Functional Movement Screen as a Reliable Physical Therapy Discharge Criteria for Chronic Lower Back Pain Patients
A clinical trial of Chronic Lower Back Pain, sponsored by Texas Back Institute.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06474429 is a study of Chronic Lower Back Pain that is actively recruiting participants, run by Texas Back Institute. The registered enrollment target is 50 participants, below the 147-participant average among 5 other Chronic Lower Back Pain trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06474429, a study of Chronic Lower Back Pain, is actively recruiting participants, sponsored by Texas Back Institute.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Overview of Research Design and Objectives This study is a prospective, concurrent cohort study aimed at evaluating the reliability of the Functional Movement Screen (FMS) as a discharge criterion for patients with chronic lower back pain (LBP) undergoing physical therapy. The primary objective is to identify a benchmark FMS score that correlates with a low risk of recurrence and high levels of functional performance post-discharge. Specific Aims and Hypotheses The study specifically aims to: Assess the effectiveness of FMS in determining discharge readiness for chronic LBP patients. The hypothesis is that a specific threshold score on the FMS can reliably indicate a patient\'s readiness for discharge, reducing the risk of recurrence and ensuring better long-term functional outcomes. Rationale for the Study Chronic LBP is a prevalent condition requiring multidisciplinary management. The FMS, widely used in athletic and military settings, has potential utility in clinical management of chronic LBP, particularly in establishing discharge criteria. This study seeks to explore this potential, addressing a gap in evidence regarding discharge benchmarks for chronic LBP patients. Procedures The study involves 50 chronic LBP patients from the Texas Back Institute. Participants will undergo their standard physical therapy regimen, supplemented by regular FMS assessments to evaluate discharge readiness. Assessments include a series of functional tasks, with scores ranging from 0 to 3 for each task, culminating in a total possible score of 21. Risks and Anticipated Benefits Risks are minimal, akin to those in low-intensity exercises. Benefits include improved discharge criteria for chronic LBP patients, potentially enhancing long-term outcomes. All procedures adhere to Good Clinical Practice and Health Insurance Portability and Accountability Act guidelines. This study\'s risks include potential loss of confidentiality, psychological, and physical risks. Phy
Conditions Studied
Study Locations (1)
Texas
- Texas Back Institute - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-04-26 |
| Est. Completion | 2026-09-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06474429
The ClinicalTrials.gov registry entry for NCT06474429 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 147-participant average among 5 other Chronic Lower Back Pain trials with a reported enrollment target (66% lower). The listed sponsor is Texas Back Institute, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Lower Back Pain appearing as the primary indexed condition, and to 0 interventions.
NCT06474429 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06474429 about?
NCT06474429 is a clinical study titled "Assessing the Functional Movement Screen as a Reliable Physical Therapy Discharge Criteria for Chronic Lower Back Pain Patients". Overview of Research Design and Objectives This study is a prospective, concurrent cohort study aimed at evaluating the reliability of the Functional Movement Screen (FMS) as a discharge criterion for patients with chronic lower back pain (LBP) undergoing physical therapy. The primary objective is ...
What is the current status of trial NCT06474429?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-04-26. Estimated completion is 2026-09-08.
What conditions does trial NCT06474429 study?
This clinical trial studies the following conditions: Chronic Lower Back Pain.
Who is sponsoring clinical trial NCT06474429?
This trial is sponsored by Texas Back Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06474429 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Lower Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
RECRUITING · NA
-
Tailored Pain Guide (TPG) Study
RECRUITING · NA
-
Photobiomodulation for Lower Back Pain Post Spinal Fusion and Decompression Surgery
RECRUITING · NA
-
Assessment of Usability and Satisfaction With a Take-home Device Presenting Sound and Body Stimulation for Back Pain
RECRUITING · NA
-
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.